Introduction
============

Irritable bowel syndrome (IBS) is the most prevalent functional digestive disorder. It negatively affects the quality of life and is associated with a significant economic burden related to direct and indirect annual health-care costs.[@b1-jnm-23-428]

A recent review shows in the general population a worldwide IBS (diagnosed by the Rome III criteria) prevalence of 1.1--29.2%.[@b2-jnm-23-428] IBS is characterized by abdominal pain and/or discomfort associated with a change of shape and/or consistency of stool. The pathophysiology of IBS is still unclear, but certainly, it involves a dysregulation of the brain-gut axis.[@b3-jnm-23-428]--[@b6-jnm-23-428] It has been clearly demonstrated that IBS patients show an increased reactivity to psychosocial stressors, with subsequent hypersensitivity leading to distension and abnormal motor pattern of the intestine.[@b3-jnm-23-428],[@b7-jnm-23-428]

Approximately 60% of patients with IBS have concomitant mood and anxiety disorders; conversely, 75% of patients with major depression and panic disorder report some IBS symptoms.[@b8-jnm-23-428] An increased intestinal response to mental stress and clinical response to drugs affecting the CNS have been detected in IBS patients,[@b4-jnm-23-428] suggesting the presence of an alteration in the neuroendocrine pathway.

Neuropeptide Y (NPY) is a polypeptide present in the central and peripheral nervous system and in the digestive tract. In healthy volunteers (HVs), there is a positive correlation between serum cortisol and NPY, which are used as activation markers of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic fibers of autonomic nervous system (ANS) axis, respectively.[@b9-jnm-23-428],[@b10-jnm-23-428] NPY can also act as a modulator between the ANS and mast cells,[@b11-jnm-23-428] linking the psycho-emotional state to the symptoms of patients with IBS. In fact, NPY can modulate the activity of mast cells through specific receptors. This activation may lead to a dysregulation of permeability and visceral sensitivity of the intestine.[@b4-jnm-23-428]

Another mediator in both the CNS and peripheral tissues is serotonin (5-hydroxytryptamine, 5-HT), which acts through its interaction with specific receptors.[@b6-jnm-23-428] In the gastrointestinal (GI) tract, 5-HT regulates sensory, secretory, and motor functions through the intrinsic and extrinsic nervous system. In particular, in a previous study,[@b5-jnm-23-428] we observed that IBS patients showed a significant association between specific psychological characteristics and neuroendocrine markers, especially plasma cortisol and NPY.

For example, endothelin-1 (ET-1) exerts vasoconstrictor and mitogenic properties on smooth muscle cells, but has also potent effects on GI smooth muscle, leading to contraction of the esophagus, stomach, and small and large intestine.[@b12-jnm-23-428] Indeed, Nowicki et al[@b13-jnm-23-428] showed that the ET-1 tissue concentration is greater in human preterm intestine with histologic evidence of necrotizing enterocolitis. Interestingly, ET-1 is able to modulate sympathetic activity in humans through type A receptors.[@b14-jnm-23-428],[@b15-jnm-23-428] To date, this interaction has been demonstrated only in hypertensive patients,[@b15-jnm-23-428] but we cannot exclude the possibility that a greater susceptibility to the sympatho-excitatory effect of ET-1 might be present in other conditions characterized by autonomic dysregulation, such as IBS. Taken together, these data suggest that a dysregulation in sympathetic activity, possibly due to neurohormonal alterations, might be implied in the pathophysiology of both vascular dysfunction and GI motility disorders. Based on these premises, the objective of this study was to assess the neuroendocrine activity in patients with IBS.

Materials and Methods
=====================

Patients
--------

Thirty patients (9 men, 21 women; mean age 38.43 ± 11.82 years; age range 19--67 years) with IBS according to the Rome III criteria[@b7-jnm-23-428] who were referred to the Gastroenterology outpatients services of a single tertiary center in Pisa, Italy, were enrolled in this study. Out of 30 IBS patients, 7 patients (2 men and 5 women) had mixed diarrhea and constipation; 12 (6 men and 6 women) had diarrhea; and 11 (1 man and 10 women) had constipation. We also enrolled 30 HVs (14 men, 16 women; mean age 47.79 ± 15.56 years; age range 27--75 years). The matter of the research was described to both the patients and the HVs. The Local Ethics Committee approved the study. Each study participant delivered written informed consent before beginning the study, in accordance with the principles of the Declaration of Helsinki (6th Revision, Seoul 2008).

Psychological Assessment
------------------------

The assessment of anxiety, personality dimensions, psychophysiological features, fears of the subjects, symptoms of depression, obsessions, and compulsions were performed using the questionnaires that were part of the Cognitive Behavioral Assessment (CBA, version 2.0).[@b16-jnm-23-428]

These questionnaires were validated on Italian populations of healthy subjects and patients with various diseases. Therefore, healthy controls who scored with significant psychological symptoms were excluded.

Neuroendocrine Markers
----------------------

Venous blood samples of patients and HVs were taken after an overnight fasting. As described previously,[@b5-jnm-23-428] levels of 5-HT, cortisol, and NPY were measured in the venous blood samples, and levels of cortisol and 5-hydroxyindoleacetic acid (5-HIAA) were also determined in one sample of 24-hour urine excretion from all patients and HVs. Endothelin (ELISA; Biomedica Medizinprodukte GmbH & Co KG, Vienna, Austria) was measured in the venous blood samples.

Microneurography Assessment
---------------------------

Fourteen out of 30 patients (8 men and 6 women) agreed to undergo microneurography.

Microneurography was used to obtain multiunit recordings of efferent postganglionic muscle sympathetic nerve activity (MSNA), as previously described.[@b15-jnm-23-428],[@b17-jnm-23-428]

All experimental sessions were performed in the morning, in a quiet and comfortable room. The microelectrodes for the MSNA recording and the other measuring devices were positioned. After 10 minutes, non-invasive beat-to-beat blood pressure (BP) (Portapres; Finapres Medical System, Enschede, The Netherlands), heart rate (Biotach; Gould Electronics, Chandler, AZ, USA), and MSNA were continuously monitored and recorded, using a digital acquisition system (ACQ-16; Gould Electronics) and a dedicated computer software (Ponemah; Data Sciences Interntional, New Brighton, MN, USA), for a 10-minute interval to obtain baseline levels. Then, acute reactivity to stress was evaluated using a mental arithmetic stress test and cold pressor test.

During the verbally administered mental arithmetic stress test, IBS patients were asked to subtract 2-digit numbers from 4-digit numbers as quickly and accurately as possible. Throughout the mental arithmetic stress test, the subjects were urged to work more quickly and more accurately.[@b18-jnm-23-428],[@b19-jnm-23-428] The cold pressor test was performed by immersing the left hand of the subject in ice water up to the wrist for 2 minutes.[@b20-jnm-23-428] MSNA was analyzed by visual inspection by a single investigator (R.M.B.). MSNA was quantified as the MSNA burst frequency (expressed in bursts/min) and incidence (expressed in bursts/100 heart beats). Absolute (D) and relative changes from baseline (D%) in MSNA, BP, and heart rate were calculated.

Statistical Methods
-------------------

Statistical analysis was performed using STATA 12 software (Stata Statistical Software, College Station, TX, USA). The data were not normally distributed, therefore all results were expressed as the median and interquartile range. Correlation analysis between 2 variables was performed using the Spearman rank correlation coefficients (*ρ*). Comparisons of continuous data were performed using the Wilcoxon signed-ranks test applied to two-sample (for comparisons between HV and IBS) or to paired samples (for comparisons between baseline and acute stressors). Statistical significance was assigned to a *P*-value ≤ 0.05.

Results
=======

Psychological Assessment
------------------------

The most prevalent psychological symptoms in IBS patients were: social maladjustment (60%), trait anxiety (40%), obsessive compulsive-disorders (23%), depressive symptoms (23%), and state anxiety (17%).

Neuroendocrine Markers
----------------------

Data are summarized in [Table 1](#t1-jnm-23-428){ref-type="table"}. Significant differences between IBS patients and HVs were found in the plasma levels of neuroendocrine markers. In particular, baseline plasma levels of NPY (31.9 \[43.7\] vs 14.8 \[18.1\] pmol/L, *P* = 0.006) and 5-HT (214.9 \[182.6\] vs 141.0 \[45.5\] pg/mL, *P* = 0.010) were significantly higher in IBS patients than in controls. Plasma endothelin showed also a trend to increased values in IBS patients.

Neuroendocrine Markers and Psychological Features
-------------------------------------------------

There were significant associations of NPY with "maladjustment" (*P* =0.050). Endothelin had a significant association with "fears for repellent animals" (*P* = 0.049) and "fears for natural disasters" (*P* = 0.043). Plasma cortisol had significant associations with "obsessive disorders" (*P* = 0.014), maladjustment (*P* \< 0.01), and "fears for repellent animals" (*P* = 0.04). Plasma 5-HT showed significant associations with "state anxiety," "trait anxiety," and "psychophysical disorders" (*P* \< 0.01). 5-HIAA had a significant association with "doubting/ruminating" (*P* = 0.020). Urinary cortisol had significant associations with "trait anxiety" (*P* = 0.044). The associations between neuroendocrine markers and psychological features are shown in [Table 2](#t2-jnm-23-428){ref-type="table"}.

Neuroendocrine Markers and Microneurography
-------------------------------------------

Hemodynamic and sympathetic variables in IBS patients at baseline and after the mental arithmetic stress test and cold pressor test are shown in [Table 3](#t3-jnm-23-428){ref-type="table"}. In 3 of 14 IBS patients, MSNA recordings during the stress tests were not readable because of artifacts due to movements and muscle contractions. IBS patients showed a significant increase in mean BP and heart rate after both mental stress and cold pressor test. Conversely, a significant rise in MSNA frequency and incidence was found only after mental stress, thus suggesting a blunted response to cold pressor test. Baseline burst frequency tended to be positively associated with urinary cortisol (*ρ* = 0.557, *P* = 0.059). Absolute and relative changes in heart rate after mental stress were also positively associated with urinary cortisol (D heart rate: *ρ* = 0.636, *P* = 0.035; D% heart rate: *ρ* = 0.682, *P* = 0.021). Absolute and relative changes in burst incidence after mental stress were also positively associated with plasma cortisol (D MSNA: *ρ* = 0.551, *P* = 0.079; D% MSNA: *ρ* = 0.671, *P* = 0.024). Plasma 5-HT tended to be inversely associated with BP response to cold pressor test (D mean BP: *ρ* = −0.582, *P* = 0.060; D% mean BP: *ρ* = −0.510, *P* = 0.090).

Furthermore, we compared individuals with diarrheic IBS subtype (n = 6) to the non-diarrheic IBS subtype (defined grouping patients with either mixed diarrhea and constipation or constipation only): microneurographic parameters at baseline were similar in the 2 groups (see [Supplementary Table](#s1-jnm-23-428){ref-type="supplementary-material"}). IBS individuals with non-diarrheic subtype had instead a blunted MSNA frequency increase after the cold pressor test compared to the diarrheic subtype (median value: +0.9 vs +6.7 bursts/min, *P* = 0.055; +19% vs +42%, *P* = 0.130). Furthermore, individuals with diarrheic subtype tended to have a blunted % MSNA incidence increase after mental stress compared to non-diarrheic subtype (median value: +19% vs +46%, *P* = 0.090), but a similar absolute change (+3.2 vs +3.5 bursts/100 hour, *P* = 0.450).

In order to demonstrate whether the present findings were specific of IBS patients, we compared microneurographic features of patients enrolled in this study to those of a group of HVs. We selected among HVs participating to previously published studies[@b15-jnm-23-428],[@b17-jnm-23-428] or unpublished protocols a group of 12 age-, sex-, and BP-matched individuals (6 men, age 40.7 ± 10.4 years), who performed a similar microneurographic protocol.

MSNA, mean BP and heart rate in resting conditions, as well as their response to mental stress, was similar in IBS individuals and in HVs ([Table 3](#t3-jnm-23-428){ref-type="table"}). Interestingly, after cold pressor test IBS patients had a blunted increase MSNA burst frequency (median value: +4.1 vs +7.8 bursts/min, *P* = 0.048; +30.1% vs +78.1%, *P* = 0.023) and incidence (median value: +3.3 vs +8.1 bursts/100 heart beats, *P* = 0.034; 15.1% vs 58.7%, *P* = 0.023) than HVs, while differences in changes in mean BP (median value + 10 vs +17 mmHg, *P* = 0.180; +13.0% vs 22.0%, *P* = 0.160) and heart rate (median value: +4 vs +7 bpm, *P* = 0.910; +7.0% vs +12.0%, *P* = 0.860) did not reach statistical significance. When different IBS subgroups were analyzed, only individuals with a non-diarrheic IBS subtype had a blunted MSNA frequency increase after cold pressor test in comparison to HVs (median value: +0.9 vs +7.8 bursts/min, *P* = 0.003).

Discussion
==========

To our knowledge, this is the first study that evaluated endothelin levels in IBS patients and found increased levels compared with HVs. Furthermore, this is the first time that muscle sympathetic nerve activity in IBS patients was studied by using direct intraneural recordings. Although we could not demonstrate any significant increase in resting sympathetic activity in IBS patients, autonomic reactivity to cold pressor test in the vascular district was blunted, particularly in the non-diarrheic IBS subtype. Furthermore, cardiovascular autonomic reactivity to mental stress positively correlated with cortisol levels, suggesting an association between HPA and sympathetic activation in this population.

The secretion of the glial cell-derived neurotrophic factor, nerve growth factor, and transforming growth factor-beta contributes to the maintenance of epithelial integrity; the secretion of endothelins might be involved in vasoregulation.[@b21-jnm-23-428] Some studies have demonstrated an altered autonomic function in IBS patients and suggest that IBS patients have increased sympathetic nervous system and cardiovascular activation.[@b22-jnm-23-428],[@b23-jnm-23-428] The endothelin system seems to exert an increased vasoconstrictive and sympathoexcitatory role in conditions characterized cardiovascular risk such as hypertension.[@b15-jnm-23-428] Moreover, some studies demonstrated that ET-1 mediates smooth muscle contraction in GI tract.[@b12-jnm-23-428]

According to previous studies,[@b5-jnm-23-428] NPY levels at baseline are higher in IBS patients than in controls. It is possible that NPY levels change during psychological distress. In fact, in the present study, NPY showed a negative association with "maladjustment" and plasma cortisol was negatively associated with "fears for repellent animals" and "obsessive-compulsive disorders." Fear occurs in response to a known threat that is external, defined, or otherwise non-conflictual in origin; anxiety occurs as a response to a threat that is unknown, internal, vague, or conflictual in origin.[@b24-jnm-23-428]

Measurement of plasma NPY levels could play an important role in the diagnosis of some functional disorders and their psychological comorbidities that are very frequently present because, in most cases, the other neuroendocrine and immune markers have only a paracrine effect. In fact, the local release of some neuropeptides into the enteric nervous system could play a role in the pathophysiology of IBS, but these neuropeptides cannot be assayed in the serum because they spread in a paracrine way. As suggested by Forbes et al[@b25-jnm-23-428] in a mouse model, NPY seems to directly inhibit the colonic motor response induced by the corticotrophin-releasing factor receptor activation during stress. Given that the local 5-HT release in the GI tract is involved in excitatory action on vagal afferent fibers and on contraction of smooth colonic muscle,[@b6-jnm-23-428] it is possible that indirect high levels of NPY try to maintain normal colonic motor response also during psychological distress, counteracting the effect of 5-HT release. Indeed, via the gut-brain axis, local 5-HT secretion contributes to central pain perception, visceral hypersensitivity, and transit modification of the GI motility pattern; however, several studies demonstrated alterations in plasma 5-HT in a specific subgroup of IBS patients but not in all IBS patients.[@b5-jnm-23-428],[@b6-jnm-23-428],[@b26-jnm-23-428]

In this study, the mean levels of plasma cortisol were not significantly different between IBS patients and controls, suggesting an uncoupling between the HPA and ANS axes. Our data are consistent with a previous study by Fukudo et al[@b27-jnm-23-428] that observed increased plasma levels of adrenocorticotropic hormone but normal levels of cortisol in response to corticotropin releasing hormone injection in IBS patients. However, our results suggest a more complex relationship between the HPA and ANS axes in IBS, with a facilitator role of the HPA axis on ANS that manifests only during conditions of acute stress. Indeed, baseline cortisol levels, a possible index of distress in this population, are associated with an increased cardiovascular autonomic reactivity to stress, as represented by the increase of MSNA during mental challenge. This result is in line with previous findings showing that in humans, injection of corticotropin increases MSNA,[@b28-jnm-23-428] while a correlation between resting MSNA and morning salivary cortisol has been observed in healthy young individuals.[@b29-jnm-23-428] Finally, a preliminary analysis according to IBS subtypes suggest that a blunted response to the cold pressor test is present in the non-diarrheic subtype. A hypo-reactivity of sympathetic central integration and/or sympathetic efferent pathways might reflect a generalized hyporesponsiveness of the ANS to stimuli, possibly underlying the clinical feature of IBS in this subgroup.

It is important to outline the methodological limitations of the study. First, IBS patients had, as expected, a significantly higher prevalence of psychological disorders in comparison to HVs. Therefore, it is not possible to demonstrate whether the altered neuroendocrine pattern shown in IBS is disease-specific or it is rather related to the psychological comorbidity. Furthermore, the control group for MSNA substudy was not recruited on purpose for this study, adding another possible source of bias, and had a small sample size; for this reason, MSNA results should be considered preliminary and interpreted with caution. It is mandatory that these aspects should be investigated in further studies with adequate sample size and appropriately selected control group in order to confirm the findings of this pilot study.

In conclusion, this study demonstrated for the first time that endothelin levels are increased in IBS patients compared to controls, suggesting a possible involvement of endothelin in autonomic disorders present in IBS patients. Furthermore, circulating levels of cortisol are related to autonomic cardiovascular reactivity to stress in this population, thus establishing a new link between the ANS and HPA axes in IBS pathophysiology. Though our study failed to demonstrate an altered sympathetic traffic directed to the vasculature, a blunted sympathetic response to cold pressor test was shown, particularly in the non-diarrheic subtypes, suggesting that multiple autonomic dysregulations might be present in this condition. Finally, higher concentrations of NPY were demonstrated in IBS patients than in controls. If this relationship is confirmed in a larger sample of IBS patients, the use of this neuropeptide could be considered as a possible diagnostic marker for IBS or could at least help to detect possible IBS psychological comorbidities.
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###### 

Neuroendocrine Markers in the Study Population

  Parameter                      Healthy volunteers   IBS patients   *P*-values           
  ------------------------------ -------------------- -------------- ------------ ------- -------
  Neuropeptide Y (pmol/L)        14.8                 18.1           31.9         43.7    0.006
  Serum cortisol (μg /dL)        15.8                 2.9            16.4         9.0     0.718
  Urinary cortisol (μg /24 hr)   27.0                 27.0           35.2         23.5    0.487
  Plasma 5-HT (ng/mL)            141.0                45.5           214.9        182.6   0.012
  5-HIAA (mg/24 hr)              9.3                  5.9            8.1          4.9     0.468
  Endothelin (pg/mL)             1.1                  1.4            2.1          8.1     0.054

IQR, interquartile range; 5-HT, 5-hydroxytryptamine (serotonin); 5-HIAA, 5-hydroxyindoleacetic acid.

###### 

Association Between Neuroendocrine Markers and Psychological Features in Irritable Bowel Syndrome Patients

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameters                         State anxiety   Trait anxiety   PD             Fears for natural disasters   Fears for repellent animals   OCD             Checking   Doubting/ ruminating   Maladjustment
  ---------------------------------- --------------- --------------- -------------- ----------------------------- ----------------------------- --------------- ---------- ---------------------- ---------------
  Neuropeptide Y (31.95 \[43.7\])    NS              NS              NS             NS                            NS                            NS              NS         NS                     *ρ* = −0.367\
                                                                                                                                                                                                  *P* = 0.050

  Serum cortisol (16.4 \[9.0\])      NS              NS              NS             NS                            *ρ* = −0.384\                 *ρ* = −0.452\   NS         NS                     *ρ* = −0.493\
                                                                                                                  *P* = 0.040                   *P* = 0.014                                       *P* \< 0.01

  Plasma 5-HT (214.85 \[182.6\])     *ρ* = 0.528\    *ρ* = 0.589\    *ρ* = 0.524\   NS                            ns                            NS              NS         NS                     NS
                                     *P* \< 0.01     *P* \< 0.01     *P* \< 0.01                                                                                                                  

  Endothelin (2.1 \[8.1\])           ns              ns              ns             *ρ* = −0.408\                 *ρ* = −0.397\                 NS              NS         NS                     NS
                                                                                    *P* = 0.043                   *P* = 0.049                                                                     

  5-HIAA (8.1 \[4.9\])               NS              NS              NS             ns                            NS                            NS              NS         *ρ* = −0.452\          NS
                                                                                                                                                                           *P* = 0.020            

  Urinary cortisol (35.2 \[23.5\])   NS              *ρ* = 0.383\    NS             NS                            NS                            NS              NS         NS                     NS
                                                     *P* = 0.044                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PD, psychophysical disorders; OCD, obsessive compulsive disorders; ns, no statistical association; ρ = Rho, Spearman rank correlation coefficient; 5-HT, 5-hydroxytryptamine (serotonin); 5-HIAA, 5-hydroxyindoleacetic acid.

Values of neuroendocrine markers are expressed as median and interquartile range.

###### 

Hemodynamic and Sympathetic Variables in Irritable Bowel Syndrome Patients at Baseline and After Mental Stress and Cold Pressor Test

                                                   Baseline   Mental stress   Cold pressor test                                                                                         
  ------------------------------------------------ ---------- --------------- ------------------------------------------------ ------ ------------------------------------------------- ------
  IBS patients                                                                                                                                                                          
   Mean BP (mmHg)                                  79.2       11.6            90.2[a](#tfn5-jnm-23-428){ref-type="table-fn"}   19.8   89.8[b](#tfn6-jnm-23-428){ref-type="table-fn"}    12.3
   Heart rate (bpm)                                69.9       16.2            87.0[a](#tfn5-jnm-23-428){ref-type="table-fn"}   29.0   81.5[b](#tfn6-jnm-23-428){ref-type="table-fn"}    33.8
   MSNA burst frequency (bursts/min)               14.9       10.4            18.3[a](#tfn5-jnm-23-428){ref-type="table-fn"}   15.3   19.5                                              12.0
   MSNA burst incidence (bursts/100 heart beats)   22.6       12.1            23.2[a](#tfn5-jnm-23-428){ref-type="table-fn"}   17.4   27.2                                              9.5
  Healthy volunteers                                                                                                                                                                    
   Mean BP (mmHg)                                  84.7       6.5             95.7[a](#tfn5-jnm-23-428){ref-type="table-fn"}   16.7   102.9[a](#tfn5-jnm-23-428){ref-type="table-fn"}   18.1
   Heart rate (bpm)                                66.6       10.0            75.0[a](#tfn5-jnm-23-428){ref-type="table-fn"}   23.5   72.8[a](#tfn5-jnm-23-428){ref-type="table-fn"}    18.2
   MSNA burst frequency (bursts/min)               10.3       8.5             15.5[a](#tfn5-jnm-23-428){ref-type="table-fn"}   10.0   19.2[a](#tfn5-jnm-23-428){ref-type="table-fn"}    18.0
   MSNA burst incidence (bursts/100 heart beats)   14.7       14.3            20.2[a](#tfn5-jnm-23-428){ref-type="table-fn"}   5.5    25.5[a](#tfn5-jnm-23-428){ref-type="table-fn"}    28.3

IBS, irritable bowel syndrome; IQR, interquartile range; BP, blood pressure; MSNA, muscle sympathetic nerve activity.

*P* \< 0.01 vs baseline.

*P* \< 0.05 vs baseline.
